Han‐Ming Lai

520 total citations
35 papers, 359 citations indexed

About

Han‐Ming Lai is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Han‐Ming Lai has authored 35 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 13 papers in Orthopedics and Sports Medicine and 12 papers in Surgery. Recurrent topics in Han‐Ming Lai's work include Rheumatoid Arthritis Research and Therapies (13 papers), Bone health and osteoporosis research (11 papers) and Bone and Joint Diseases (6 papers). Han‐Ming Lai is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Bone health and osteoporosis research (11 papers) and Bone and Joint Diseases (6 papers). Han‐Ming Lai collaborates with scholars based in Taiwan, Germany and United States. Han‐Ming Lai's co-authors include Tien‐Tsai Cheng, Shan‐Fu Yu, Ying‐Chou Chen, Chung‐Yuan Hsu, Wen‐Chan Chiu, Jia‐Feng Chen, Yu‐Jih Su, Chung‐Jen Chen, Su‐Shin Lee and Shun‐Jen Chang and has published in prestigious journals such as Frontiers in Immunology, Medicine and Lara D. Veeken.

In The Last Decade

Han‐Ming Lai

34 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han‐Ming Lai Taiwan 12 177 117 104 99 78 35 359
Beth J. Kirby Canada 10 52 0.3× 76 0.6× 41 0.4× 99 1.0× 82 1.1× 20 316
L. Ichchou Morocco 8 73 0.4× 137 1.2× 75 0.7× 12 0.1× 51 0.7× 43 295
Dihua Zhang China 8 40 0.2× 57 0.5× 49 0.5× 162 1.6× 100 1.3× 16 348
Jieyu He China 9 74 0.4× 52 0.4× 55 0.5× 30 0.3× 110 1.4× 20 438
Guillermo Martínez Diaz‐Guerra Spain 10 28 0.2× 128 1.1× 65 0.6× 86 0.9× 48 0.6× 52 310
Natalia Campos‐Obando Netherlands 11 17 0.1× 132 1.1× 42 0.4× 103 1.0× 49 0.6× 15 316
Stefania Sella Italy 10 16 0.1× 112 1.0× 73 0.7× 108 1.1× 52 0.7× 26 420
Aiji Yajima Japan 13 21 0.1× 134 1.1× 76 0.7× 290 2.9× 48 0.6× 30 424
Sarah Keller United States 8 84 0.5× 12 0.1× 55 0.5× 185 1.9× 67 0.9× 13 330
Chiara Sonato Italy 9 16 0.1× 72 0.6× 91 0.9× 186 1.9× 69 0.9× 18 356

Countries citing papers authored by Han‐Ming Lai

Since Specialization
Citations

This map shows the geographic impact of Han‐Ming Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han‐Ming Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han‐Ming Lai more than expected).

Fields of papers citing papers by Han‐Ming Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han‐Ming Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han‐Ming Lai. The network helps show where Han‐Ming Lai may publish in the future.

Co-authorship network of co-authors of Han‐Ming Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Han‐Ming Lai. A scholar is included among the top collaborators of Han‐Ming Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han‐Ming Lai. Han‐Ming Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jia‐Feng, Shan‐Fu Yu, Wen‐Chan Chiu, et al.. (2024). Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics. 14(4). 452–452. 2 indexed citations
2.
Yu, Shan‐Fu, Jia‐Feng Chen, Ying‐Chou Chen, et al.. (2022). The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis—A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study. Frontiers in Medicine. 9. 885801–885801. 2 indexed citations
3.
Yu, Shan‐Fu, Ming‐Han Chen, Jia‐Feng Chen, et al.. (2022). Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis–associated fragility fracture: a 3-year longitudinal, observational, cohort study. Therapeutic Advances in Chronic Disease. 13. 374126665–374126665. 5 indexed citations
4.
Chen, Ming‐Han, Shan‐Fu Yu, Jia‐Feng Chen, et al.. (2021). Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study. Frontiers in Immunology. 12. 783030–783030. 11 indexed citations
5.
Hsu, Chung‐Yuan, Jia‐Feng Chen, Yu‐Jih Su, et al.. (2020). Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes. Therapeutic Advances in Chronic Disease. 11. 1754273293–1754273293. 7 indexed citations
6.
7.
Yu, Shan‐Fu, Jur‐Shan Cheng, Ying‐Chou Chen, et al.. (2019). Adherence to anti-osteoporosis medication associated with lower mortality following hip fracture in older adults: a nationwide propensity score-matched cohort study. BMC Geriatrics. 19(1). 290–290. 19 indexed citations
8.
Wu, Chih-Hsing, et al.. (2019). Novel algorithm generating strategy to identify high fracture risk population using a hybrid intervention threshold. Journal of Bone and Mineral Metabolism. 38(2). 213–221. 3 indexed citations
9.
Lai, Han‐Ming, et al.. (2017). Beyond bone mineral density, FRAX-based tailor-made intervention thresholds for therapeutic decision in subjects on glucocorticoid. Medicine. 96(5). e5959–e5959. 12 indexed citations
10.
Tu, Hung‐Pin, Chia‐Min Chung, Albert Min‐Shan Ko, et al.. (2016). Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk. Journal of Human Genetics. 61(9). 803–810. 13 indexed citations
11.
Tu, Hung‐Pin, Albert Min‐Shan Ko, Shang‐Lun Chiang, et al.. (2014). Joint Effects of Alcohol Consumption and ABCG2 Q141K on Chronic Tophaceous Gout Risk. The Journal of Rheumatology. 41(4). 749–758. 31 indexed citations
12.
Tsai, Tong‐Rong, Yu‐Chiang Hung, Shun‐Jen Chang, et al.. (2011). Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare‐up. The Kaohsiung Journal of Medical Sciences. 27(7). 251–257. 17 indexed citations
13.
Chen, WenChieh, Shenlin Huang, Min‐Chien Tsai, et al.. (2009). Nephrogenic systemic fibrosis in advanced chronic kidney disease: A single hospital’s experience in Taiwan. European Journal of Dermatology. 19(1). 44–49. 10 indexed citations
14.
Lai, Han‐Ming & Chung‐Jen Chen. (2008). Biologics in the treatment of rheumatoid arthritis: recent advances. 22. 12–24. 2 indexed citations
15.
Su, Yu‐Jih, Han‐Ming Lai, Chung‐Jen Chen, et al.. (2007). Ischemia heart disease and greater waist circumference are risk factors of renal function deterioration in male gout patients. Clinical Rheumatology. 27(5). 581–586. 5 indexed citations
16.
Lai, Han‐Ming, Ying‐Chou Chen, Shan‐Fu Yu, et al.. (2006). The Diagnostic Value of Anti-CCP and Rheumatoid Factor for Patients with Refractory Rheumatoid Arthritis (RA) and RA in Remission. 20. 25–30. 1 indexed citations
17.
Wang, Shih‐Wei, Chung‐Jen Chen, Tien‐Tsai Cheng, et al.. (2004). Inpatients with Allopurinol Hypersensitivity Syndrome: Experiences at a Medical Center in Southern Taiwan. 18. 23–33. 1 indexed citations
18.
Lin, Wei-Che, et al.. (2004). The Role of Imaging Studies of Percutaneous Vertebroplasty in 63 Patients with Osteoporotic Compression Fracture: Preliminary Report. 29(4). 177–184. 2 indexed citations
19.
Cheng, Tien‐Tsai, Han‐Ming Lai, Hsueh‐Wen Chang, & Shue‐Fen Luo. (2004). Elevated serum homocysteine levels for gouty patients. Clinical Rheumatology. 24(2). 103–106. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth J. Kirby Breakdown of academic impact, for papers by L. Ichchou Breakdown of academic impact, for papers by Dihua Zhang Breakdown of academic impact, for papers by Jieyu He Breakdown of academic impact, for papers by Guillermo Martínez Diaz‐Guerra Breakdown of academic impact, for papers by Natalia Campos‐Obando Breakdown of academic impact, for papers by Stefania Sella Breakdown of academic impact, for papers by Aiji Yajima Breakdown of academic impact, for papers by Sarah Keller Breakdown of academic impact, for papers by Chiara Sonato
Rankless by CCL
2026